Methotrexate-induced optic neuropathy

被引:11
作者
Balachandran, C
McCluskey, PJ
Champion, GD
Halmagyi, GM
机构
[1] Royal Prince Alfred Hosp, Dept Ophthalmol, Sydney, NSW, Australia
[2] Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia
[3] St Vincents Hosp, Dept Ophthalmol, Sydney, NSW 2010, Australia
[4] St Vincents Hosp, Dept Rheumatol, Sydney, NSW 2010, Australia
关键词
methotrexate; optic neuropathy; rheumatoid arthritis; side-effect;
D O I
10.1046/j.1442-9071.2002.00578.x
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
A 53-year-old Caucasian woman with long-standing, well controlled, severe rheumatoid arthritis, treated with methotrexate, salazopyrin, naprosyn, prednisone and plaquenil, presented with progressive visual loss in each eye. She had a past history of non-necrotizing anterior scleritis that was treated with increased doses of prednisone. She developed left then right central scotomas, reduced vision and optic atrophy. Eventually a diagnosis of methotrexate-induced optic atrophy was made.
引用
收藏
页码:440 / 441
页数:2
相关论文
共 4 条
[1]
BOOGERD W, 1990, CANCER, V65, P452, DOI 10.1002/1097-0142(19900201)65:3<452::AID-CNCR2820650313>3.0.CO
[2]
2-8
[3]
VISUAL-FIELD DEFECTS DURING LOW-DOSE METHOTREXATE THERAPY [J].
JOHANSSON, BA .
DOCUMENTA OPHTHALMOLOGICA, 1992, 79 (01) :91-94
[4]
Methotrexate therapy for chronic noninfectious uveitis - Analysis of a case series of 160 patients [J].
Samson, CM ;
Waheed, N ;
Baltatzis, S ;
Foster, CS .
OPHTHALMOLOGY, 2001, 108 (06) :1134-1139